Company / Operating Income
Oncology Institute, Inc. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$60.1M
FY2025
5-year range
-$82.0M / -$8.2M
FY2021-FY2025
Trend
+21.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$82M to -$60M over the past 2 years.
Based on SEC 10-K filings.
-$60M in FY2025.
Improved from -$82M to -$60M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 21.9% year-over-year.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$60.1M | +21.9% |
| FY2024 | -$77.0M | +6.0% |
| FY2023 | -$82.0M | -78.7% |
| FY2022 | -$45.9M | -459.4% |
| FY2021 | -$8.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026